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Objective: To determine whether the concomitant administration of ketoprofen, a non-
steroidal anti-inflammatory drug (NSAID) has any effect on the pleurodesis induced by talc
or doxycycline in rabbits.
Methods: Four groups of seven New Zealand rabbits were assigned to receive the following
treatments: 400mg/kg of talc intrapleurally only (group 1), 400mg/kg of talc plus 1mg/kg
of ketoprofen intramuscularly (group 2), 10mg/kg of doxycycline intrapleurally only
(group 3) and 10mg/kg of doxycycline plus 1mg/kg of ketoprofen intramuscularly (group
4). Intramuscular administration of ketoprofen began 4 h before the intrapleural
administration of the sclerosing agents, followed by twice daily administrations for 1
week. Pleural fluid was collected 24, 48 and 72 h after intrapleural injections. Pleurodesis
was evaluated macroscopically and microscopically after 14 days.
Results: The concomitant use of ketoprofen at 1mg/kg does not decrease the WBC, LDH,
and protein in pleural fluid at 24 h following intrapleural injection of talc or doxycycline.
There were no significant differences in the macroscopic pleurodesis scores, the degree of
microscopic pleural fibrosis, the thickness of the pleura or the percent of the pleura
occupied with angiogenesis.
Conclusions: The study shows that the short-term systemic administration of NSAIDs does
not affect the efficacy of pleurodesis induced by talc or doxycycline in rabbits.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Pleurodesis is a common treatment for patients with
symptomatic recurrent pleural effusions or spontaneous
pneumothorax. Many different agents have been adminis-
tered into pleural cavity to induce a pleurodesis. It is
thought that most of these agents induce the pleurodesis by
injuring the pleura which leads to inflammation in the
pleural space and subsequently pleurodesis if the degree of
inflammation is sufficient.1 We have shown previously that
when pleurodesis is induced in rabbits with talc or
doxycycline, the concomitant use of systemic corticoster-
oids decreases the inflammatory process and diminishes the
efficacy of the pleurodesis.2,3
Non-steroidal anti-inflammatory drugs (NSAIDs) are
widely used as post-surgery analgesics in the management
of pain associated with inflammatory conditions. Since
inflammation is crucial for the production of pleurodesis, a
reasonable question is whether NSAIDs adversely affect the
production of a pleurodesis. Ketoprofen, an NSAID, is a
reversible, short-acting, non-selective cyclooxygenase in-
hibitor, which particularly blocks the synthesis of thrombox-
ane. Under in vitro conditions, it has been shown that
ketoprofen stabilizes lysozomal membranes, restrains the
secretion of lysozomal enzymes from granulocytes, and
prevents the aggregation of platelets as well as the
immigration of leukocytes.4 However, there is no study
examining the effects of ketoprofen on pleurodesis.
The aim of this study was to evaluate the effects of
ketoprofen on the pleurodesis in rabbits resulting from talc
or doxycycline. We hypothesized that the administration of
ketoprofen would attenuate the pleural inflammation
induced by talc or doxycycline and thus decrease the
efficacy of pleurodesis in rabbits.
Materials and methods
Surgery procedure
The protocol was approved by Vanderbilt University Institu-
tional Animal Care and Use Committee. The methods used
were similar to those we have described previously.5–7 New
Zealand white rabbits weighing 1.5–2.0 kg were anesthe-
tized with 35mg/kg ketamine hydrochloride (Fort Dodge
Animal Health Laboratories; Fort Dodge, IA.) plus 5mg/kg
xylazine hydrochloride (Fermenta; Kansas City, MO) intra-
muscularly. The chest was shaved and cleansed with 10%
povidone iodine (Baxter, Deerfield, IL). A small skin incision
(o2 cm) was made between the tip of the scapula and the
sternum approximately 2 cm above the costal margin. With
the rabbit in the supine position, a chest tube, which was
made from intravenous solution set tubing (Braintree
Scientific, Braintree, MA) with five extra openings near the
distal end, was inserted into the right pleural cavity by blunt
dissection. The pleural cavity was closed and the chest tube
was fixed with a purse-string suture. The exterior end of the
chest tube was tunneled under the skin, drawn out of the
skin posteriorly between two scapulae and sealed with a
two-way valve with cap (Medexinc, Hilliard, OH) via an
adapter and sutured to the skin. Air was aspirated from the
right pleural cavity with a 20 cc syringe.After chest tube placement seven rabbits were assigned
to each of the following treatment groups: 400mg/kg talc in
2ml saline intrapleurally (talc control group, n ¼ 7) 400mg/
kg talc in 2ml saline plus ketoprofen 1mg/kg twice a day
intramuscularly (talc pre-treatment group, n ¼ 7) 10mg/kg
doxycycline in 2ml saline intrapleurally (doxycycline control
group, n ¼ 7) 10mg/kg doxycycline in 2ml saline intrapleu-
rally plus ketoprofen 1mg/kg twice a day intramuscularly
(doxycycline pre-treatment group, n ¼ 7). Ketoprofen
(1mg/kg) was started 4 h before the intrapleurally admin-
istration of the agents and was administered twice a day
intramuscularly thereafter for 1 week. Gentamicin 2mg/kg
was administered intramuscularly during the surgery and at
24 h intervals as long as the chest tubes were in place. The
chest tube was removed when the pleural fluid drainage was
less than 2ml over the preceding 24 h.
The pleural space was aspirated every 24 h after chest
tube placement and the volume of the fluid was recorded.
The protein and lactate dehydrogenase (LDH) levels at 24 h
were determined with an automated analyzer (Johnson &
Johnson, Rochester, NY). The upper limit of normal for
serum LDH was 220 IU/l. Total leukocyte count was
measured using an automated counter (Coulter Electronics,
Luton, UK).
The rabbits were sacrificed 14 days following chest
placement. At sacrifice, the rabbit was anesthetized with
pentobarbital (150mg/kg ip) and then asphyxiated with
CO2. The thorax was removed en bloc. The lungs were
expanded by the injection of 50ml of 10% neutral-buffered
formalin into the exposed trachea via a plastic catheter
(6mm diameter). Then the trachea was ligated and the
entire thorax submerged into 10% neutral-buffered formalin
solution for at least 48 h before the pleurodesis was graded.
Grading of pleurodesis score
The grading system for the pleurodesis score was on a scale
of 1–8 as described in our previous studies.5–7 The grading
procedure was performed by two investigators (R.W.L. and
K.B.L.) who were blinded to the treatment group of the
rabbit.
The degree of pleurodesis was evaluated as follows:1. No adhesions between the visceral and parietal pleura.
2. Rare adhesions between the visceral and parietal pleura
but not symphysis.
3. A few scattered adhesions between the visceral and
parietal pleura but not symphysis.
4. Many adhesions between the visceral and parietal pleura,
but no symphysis.
5. Many adhesions between the visceral and parietal pleura
and a minimal amount of symphysis (o 5%) of total area
of hemithorax.6. Many adhesions between the visceral and parietal
pleura—symphysis in 5–25% of the hemithorax.7. Many adhesions between the visceral and parietal
pleura—symphysis in 25–50% of the hemithorax.8. Many adhesions between the visceral and parietal
pleura—symphysis in450% of the hemithorax.
Adhesions were defined as fibrous connections between
the visceral and parietal pleura whereas the symphysis was
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that they were difficult to separate due to adhesions.Microscopic examination of pleura
Pleural fibrosis
Samples of the visceral pleura and lung from the right
hemithorax were collected and placed in 10% neutral
buffered formalin. The tissue samples were stained with
hematoxylin-eosin (H&E) for histologic examination. The
pleural inflammation and fibrosis were graded as none (0),
equivocal (1), mild (2), moderate (3), or severe (4), as
previously described.2,3,7 The thickness of visceral pleura
was measured using he Leica Q500IW Imaging Workstation,
Image Processing and Analysis System (Leica Imaging
Systems Ltd., Cambridge, UK). With this system, the image
obtained was transformed from pixels to micrometers.
Measurements were obtained at 10 different points on each
sample, and the mean of these 10 measurements was
reported.Pleural angiogenesis
The degree of pleural angiogenesis (vascular density) was
measured by immunostaining for factor VIII antigen (von
Willebrand factor) as we have described previously.5 The
sections were incubated with anti-factor VIII (Dako Cytoma-
tion; Carpinteria, CA) at a dilution of 1:900 for 30min. The
Dako Envision System, DAB+/Peroxidase (Dako Cytomation,
Carpinteria, CA) was used to produce localized, visible
staining. Slides were lightly counterstained with Mayer
hematoxylin, dehydrated, and cover lipped. Image ProPlus
software (Media Cybernetics; Silver Springs, MD) was used to
analyze tissue sections viewed on the stage of a Vanox light
microscopy interfaced via a Progressive Research Digital
Camera (Konatron Electronik; Munich, Germany). Two
sections randomly selected from each visceral pleural
sample were analyzed. Within each section, measurements
of 10 random fields were performed, and the mean result
was reported. The degree of pleural angiogenesis was
semiquantitated by measuring the percent of the area
occupied by endothelial cells. Since factor VIII immunostain-
ing selectively highlights only the endothelial components of
the pleural tissues, the percentage of the area occupied by
microvessels can be assessed via computer-assisted digital
analysis. The Image ProPlus color scale was adjusted toTable 1 Pleural fluid characteristics at 24 h after intrapleural
Pleural fluid Groups
Ketoprofen+doxycycline
Volume (ml) 24 h 6.371.3
48 h 5.671.9
72 h 2.971.5
WBC (cells/ul) 24 h 26017719
LDH (IU/l) 24 h 31477771
Protein (g/l) 24 h 3.270.2recognize brown staining in areas representing immunos-
tained microvessels.
Statistics
The data were presented as mean7SEM (standard error of
mean). The unpaired Student’s t-test was used to compare
the values for the animals that did and did not receive
ketoprofen in the doxycycline group and the talc group. The
pleural fluid volume, white blood cell (WBC) count, LDH,
pleurodesis score, degree of inflammation and amount of
vascularity in rabbits that received ketoprofen were
compared with the results in the rabbits that did not
receive ketoprofen in both the doxycycline group and the
talc group with the unpaired t-test. In order to determine
the number of rabbits for each group, we assumed that a 1.0
difference in the pleurodesis score would be significant and
that the standard deviation of the pleurodesis score in each
group would be 0.5 units. With these assumptions the power
of the test was 0.929. All data will be analyzed with a Sigma
Stat V2.03 software program (San Rafael, CA, USA).
A P value of less than 0.05 was considered statistically
significant.
Results
Pleural fluid characteristics
The administration of ketoprofen did not significantly
decrease the degree of pleural inflammation as indicated
by the volume or the characteristics of the pleural fluid.
There were no significant differences in the volume or the
characteristics of the pleural fluid from the rabbits that
received ketoprofen in comparison with their control group
(Table 1).
Macroscopic pleural adhesions
The administration of ketoprofen did not significantly
influence the pleurodesis scores (Fig. 1). The mean
pleurodesis score of talc control group (4.4370.90) did
not differ significantly (P40.05) from the group that also
received ketoprofen (6.0070.29). The mean pleurodesis
scores of doxycycline control group (7.4370.35) did not
differ significantly from the group that also received
ketoprofen (7.0070.38).injection of doxycycline or talc.
Doxycycline Ketoprofen+talc Talc
3.871.5 1.370.3 1.870.8
4.271.9 0 0
2.871.7 0 0
328671030 27857568 353271335
17257341 444271014 35767910
2.770.3 2.970.4 3.470.5
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Figure 1 Macroscopic pleurodesis score.
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Figure 2 Pleural fibrosis of rabbits after intrapleural injection of
doxycycline or talc with or without administration of ketoprofen
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Figure 2 Pleural fibrosis of rabbits after intrapleural injection
of doxycycline or talc with or without administration of
ketoprofen.
Groups
Vi
sc
er
al
 p
le
ur
al
 th
ic
kn
es
s 
(u
m)
0
50
100
150
200
250
Figure 3  Thevisceral pleural thickness of rabbits given doxycycline
or talc with and without ketoprofen
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Figure 3 The visceral pleural thickness of rabbits given
doxycycline or talc with and without ketoprofen.
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Figure 4  Quantative assessment of the degree of pleural angiogenesis
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Figure 4 Quantitative assessment of the degree of pleural
angiogenesis.
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Pleural fibrosis and thickness
There were no significant differences (P40.05) in the
microscopic grading score for pleural fibrosis between the
talc control group (2.2570.39) and the pre-treatment talc
group (3.0270.28), or between the doxycycline control
group (2.4770.30) and the pre-treatment doxycycline group
(2.4270.24) (Fig. 2). The rabbits that were pretreated with
ketoprofen showed no significant difference from those
given only doxycycline or talc in the thickness of the visceral
pleura (Fig. 3).Pleural angiogenesis
The administration of ketoprofen did not appear to decrease
the degree of visceral pleural angiogenesis (Fig. 4). The
vascular densities (percentage of the area) in rabbits that
received talc with and without ketoprofen were
3.36%70.28% and 4.09%71.36%, respectively, and in rabbits
that received doxycycline with and without ketoprofen were
3.09%70.74% and 4.42%70.77%, respectively. There were
no significant differences in the degree of visceral pleuralangiogenesis measured by immunostaining for factor VIII
between ketoprofen pretreated rabbits and control rabbits
(P40.05).Discussion
The present study demonstrates that the pre-treatment of
ketoprofen at 1mg/kg does not decrease the WBC, LDH, and
protein in pleural fluid at 24 h following intrapleural
injection of talc or doxycycline. Furthermore, the short-
term administration of ketoprofen at 1mg/kg twice daily for
one week does not reduce the efficacy of pleurodesis
induced by talc or doxycycline in rabbits at 14 days. There
were no significant differences in the macroscopic pleurod-
esis scores, the degree of microscopic pleural fibrosis, the
thickness of the pleura or the percent of the pleura occupied
with angiogenesis.
The mechanism of pleurodesis induced by most of the
agents such as talc and doxycycline is not fully understood.
It is commonly accepted that pleural inflammation plays a
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inflammation is characterized by denudation of mesothelial
cells, infiltration of neutrophils, development of exudative
pleura fluid, increased vascular permeability and angiogen-
esis of pleura.1,8 Many kinds of cells, cytokines and
fibrogenesis factors are involved in this process. Corticos-
teroids which have potent effects on inhibiting both the
early and the latter manifestations of inflammation reduce
the efficacy of pleurodesis. The results of our previous study
showed that the pre-treatment and then weekly adminis-
tration of systemic corticosteroids (triamcinolone, 0.8mg/
kg) essentially prevented an effective pleurodesis at 28 d.2
However, there is still controversy whether inflammation
plays a pivotal role in the production of a pleurodesis, since
the intrapleural administration of transforming growth
factor (TGF)-beta can induce an effective pleurodesis
without inducing a significant inflammatory response and
the production of the pleurodesis is not inhibited by the
systemic administration of corticosteroids.9
NSAIDs are currently used as anti-inflammatory drugs and
analgesics due to their property of inhibiting cyclooxy-
genases (COX) that are involved in the formation of
prostanoids. Two isoforms COX-1 and COX-2 exist, and
COX-2 is thought to be the main source of prostanoids
during inflammation.10–13 In the model of carrageenan-
induced pleurisy in rats, Vinegar et al.14 showed that the
early (o48 h) inflammatory response in subpleural tissue is
depressed by NSAIDs (aspirin and indomethacin) while
corticosteroids decrease both the early and the late
inflammatory response. Since systemic corticosteroids de-
crease the effectiveness of pleurodesis,2 the question is
whether the use of NSAIDs can negatively affect the
pleurodesis induced by sclerosing agents.
There are several previous studies15,16 that have been
published on the effect of NSAIDs on pleurodesis. Lardinois
et al.15 demonstrated that daily use of 2mg/kg diclofenac
for three weeks decreased the quality of pleurodesis in pigs
after mechanical pleural abrasion. In a second study Teixeira
et al.16 administrated 1.1mg/kg diclofenac sodium intra-
muscularly to rabbits that were given silver nitrate or talc
before, then daily for seven days and thereafter weekly
until the animals were sacrificed on day 28. They found that
silver nitrate induced more pleural inflammation and more
effective pleurodesis than did talc, In addition, the
sustained systemic administration of NSAIDs reduced the
degree of pleural adhesions in animals that received talc but
not in those that received silver nitrate. They speculated
that the anti-inflammatory agents did not reduce the
pleurodesis score in rabbits receiving silver nitrate because
the silver nitrate induced a greater inflammatory response
which was still sufficient after the NSAIDs to result in a
pleurodesis.
Why do the results in the present study differ from those
of previous studies? There are several possible explanations.
First, the NSAIDs used in our study are different from those
used in previous studies. Ketoprofen, which used in our
study, is relatively COX-1 selective, whereas diclofenac,
which was used in previous studies, is relatively COX-2
selective. In general, the COX-2 enzyme is believed to
locate at sites of inflammation and COX-1 enzyme is thought
to be mainly within stomach and duodenum.10,11 However, it
should be noted that until to date, there is no evidence thatthe more selective COX-2 NSAIDs are more effective anti-
inflammatory agents than are the in the less selective COX-2
NSAIDs. Second, the length of time that the NSAIDs
administered is different. In present study, ketoprofen was
administered for 1 week, whereas in the other studies
diclofenac was used for 3–4 weeks until the animals were
sacrificed. Third, the conflicting results could be due to
different doses of the NSAIDs. This is unlikely because the
ketoprofen dose used in the present study and diclofenac
doses used in the previous studies are the recommended
dose in humans.11
In addition to the pleurodesis scores, other data from the
present study supports our conclusions that ketoprofen does
not affect the inflammatory response or the resulting
pleurodesis. Ketoprofen had no effect on the levels of the
WBC and LDH. These inflammatory markers had not been
measured in the two previous studies on NSAIDs and pleurod-
esis.15,16 In our previous study,5 we showed that the degree of
angiogenesis was closely correlated with the degree of
pleurodesis. However, in the present study the administration
of ketoprofen had no effect on the pleural angiogenesis.
The present study has important clinical implications. It
demonstrates that the use of NSAIDs for the first 7 days after
a pleurodesing agent is injected does not significantly
reduce the effectiveness of pleurodesis. In clinical practice
anti-inflammatory agents are frequently used for a few days
in patients with chest tubes who undergo pleurodesis.
However, we cannot eliminate the possibility that the
administration of NSAIDs for a longer period may have a
negative effect on pleurodesis.
Some limitations of our study should be noted. First, we
notice that some inflammatory parameters seem higher in the
NSAID group while some are lower and that there is no
consistent pattern. This indicates that number of rabbits in
each group, according to the power analysis, may be not
enough to detect the difference with a P value lower than 0.5.
Second, the study was done in rabbits and one must always be
careful in extrapolating results in animals to human adults,
This may be particularly important since rabbits have a thin
visceral pleura while humans have a thick visceral pleura.
In conclusion, the present study demonstrates that the
short-term systemic administration of NSAIDs does not
affect the efficacy of pleurodesis induced by talc or
doxycycline in rabbits. The effect of NSAIDs on pleurodesis
in human requires confirmation in a clinical trial.
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